Flash news

MR guided Focused Ultrasound Therapy

ExAblate uses MR guided focused ultrasound (MRgFUS) technology that combines MRI and high intensity focused ultrasound to thermally ablate tumors inside the body, non-invasively. The uniqueness of focused ultrasound guided by MR is its ability to monitor treatment outcome and control treatment parameters to achieve the planned outcome in real time. More than 9000 patients worldwide.

Two applications of  ExAblate are  commercially approved in the United States:

The treatment of symptomatic uterine fibroids

Pain palliation of bone metastastases for patients who cannot or choose not to undergo radiation

and there are ongoing clinical trials for other applications.

  Key benefits of ExAblate treatment:

  • Short recovery time, quick symptom relief
  • Non-invasive, non-ionizing treatment with minimal discomfort and trauma
  • One session, drug-sparing, no hospitalization
  • No incisions, scars, post-operative complications or long-term sequelae
  • Safe and effective
This text will be replaced
Listen to doctors experience treating patinets with ExAblate for bone
Listen to a patient story for bone treatment‚ as told by Dr. Mark Hurwitz
A bone metastasis patient from Philadelphia‚ as told by Dr. Josh Meyer
Listen to doctors and patients talk about their experience with a non-invasive treatment for uterine fibroids